JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home Page

[Notice] 2022 Price changes

Bioneer, COVID, COVID19, COVID-19, Omicron

[Notice] BIONEER tracks the targeted SARS-CoV-2 mutations

SARS-CoV-2 mutations, SARS-CoV-2, COVID-19

[Notice] AccuPower®SARS-CoV-2 Variants ID Real-Time RT-PCR Kit (RUO)

[Notice] Guide for Dispensing the Samples in a Multi-Well Plate

[Notice] S gene Amplification Kit for SARS-CoV-2 S gene mutation analysis is released!

[Notice] COVID-19 Diagnostic Assay

[Notice] Notice for Column Performance Improvement for 4 AccuPrep Kit

[Notice] BIONEER Viral Load Test Kit (HIV, HBV, HCV), Asia 1st CE List A approval!

[Notice] Meet our faster gene synthesis services unlike before!

[News] Launching AccuLoader, the world’s first patented precision auxiliary device for sample loading

AccuLoader

On February 25, 2021, BIONEER Corporation announced the launching of a new concept auxiliary device, “AccuLoader™,” designed to assist with the dispensation of samples and reagents to the correct wells and reduce the time spent on the sample preparation.

AccuLoader™ is the world’s first patented precision auxiliary device developed by BIONEER Corporation. It can be applied to various molecular diagnostic tests, including COVID-19 tests. The device has a variety of functions ranging from scanning the information on a sample tube to automatically adjusting the position of the well for correct sample dispensation. It is also equipped with parts that aid in minimizing the chances of cross-contamination. Moreover, its dedicated mobile app, the “AccuLoader,” allows for managing and merging of all sample information collected from the same run.

For more information, please refer to our Press Release.